Autonomix Medical, Inc. AMIX
Set alert
At close · Oct 30
After hours · Oct 30, 7:43 PM ET
- YTD
- -84.33%
- 1 year
- -91.63%
- Open
- 2.08
- Prev close
- 2.06
- Mkt cap
- 3.55M
- Vol
- 135.41K
- Avg vol
- 3.03M
- EPS
- -39.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.81
- High
- 2.15
- Forward P/E
- -0.46
- Beta
- 0.00
- Short ratio
- 0.06
- Inst. own
- 17.72%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 8.29
- 200-d avg
- 26.81
- 1y target
- 28.00
5D chart
Signals (37)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 4:00 PM | 2 days ago |
| RSI: Oversold | Oct 30, 4:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:30 PM | 2 days ago |
| RSI: Oversold | Oct 30, 1:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 10:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 12:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 5 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:05 PM | 6 days ago |
News
1 month ago globenewswire.com
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
Patent expands protection for catheter-based technologies enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall
-
1 month ago benzinga.com
Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform
Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the successful completion…
1 month ago globenewswire.com
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
FDA pre-submission feedback supports a Class II strategy, leveraging substantial equivalence to a previously cleared device, positioning the Company for potential initial U.S. clearance of its…
-
1 month ago benzinga.com
Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye
Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the grant of European Patent
1 month ago globenewswire.com
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
European patent strengthens protection for proprietary autonomic nervous system assessment technologies, further expanding Company's international patent portfolio
1 month ago globenewswire.com
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies
2 months ago globenewswire.com
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
Abstracts highlight potential of Autonomix's transvascular technology across pain management and nervous system mapping THE WOODLANDS, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.…
-
2 months ago benzinga.com
Autonomix Medical Announces Issuance Of U.S. Patent Titled 'Systems And Methods For Regulating Organ And/Or Tumor Growth Rates, Function, And/Or Development' On August 25
U.S. Patent No. 12,714,780 by the United States Patent and Trademark Office (USPTO), titled "Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development" on…
2 months ago globenewswire.com
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer…
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.0 million. Summit Therapeutics…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa…
-
2 months ago benzinga.com
Market-Moving News for August 25th
AMIX: 126% | Autonomix Medical shares are trading higher ahead of the Patent and Trademark Office's decision to grant the company U.S. Patent No. 12,714,780 titled "Systems and Methods for Regulating…
2 months ago benzinga.com
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Cadeler A/S (NYSE: CDLR) surged in pre-market trading after reporting strong financial results for the first half of 2026. Revenue and profit increased significantly, and full-year guidance…
2 months ago benzinga.com
Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why
Autonomix Medical shares surge 117% after hours following a $4.9 million warrant inducement deal.
2 months ago globenewswire.com
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted…
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's after-market session. The company's market cap stands at $5.1 million. Picard Medical (AMEX:PMI) stock…
-
2 months ago benzinga.com
Autonomix Medical Will Be Granted U.S. Patent No. 12,714,780 Tomorrow (August 25, 2026), Titled “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.”
https://patentcenter.uspto.gov/applications/17971202/ifw/docs?application=
-
2 months ago benzinga.com
Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) Estimate
Autonomix Medical (NASDAQ:AMIX) reported quarterly losses of $(5.02) per share which beat the analyst consensus estimate of $(6.93) by 27.56 percent. This is a 77.66 percent increase over losses of…
2 months ago globenewswire.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Final histology and laboratory analyses support the study's safety and performance objectives THE WOODLANDS, TX, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix”…
2 months ago globenewswire.com
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX)…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma…
2 months ago benzinga.com
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares rose 13% in pre-market trading.
2 months ago benzinga.com
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. stock indexes finished higher on Tuesday, with the Dow Jones Industrial Average climbing 1.71% to 54,085.88.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday's after-market session. American Well (NYSE:AMWL) stock rose 12.76% to $11.75. The market value of their…
2 months ago benzinga.com
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
Autonomix Medical Inc. (NASDAQ:AMIX) shares are skyrocketing Tuesday afternoon after securing U.S. Patent No. 12,433,670.
2 months ago benzinga.com
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
Autonomix Medical is skyrocketing Tuesday after securing U.S. Patent No. 12,433,670, expanding protection for its nerve-mapping platform.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares…
2 months ago benzinga.com
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings
Dow rises 1.35% with technology sector leading market gains. Pfizer beats Q2 earnings expectations. Oil down 4.2%, gold up 0.8%, European markets higher.
-
2 months ago benzinga.com
Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function'
The patent expands the Company’s intellectual property protection for technologies designed to sense, map and selectively target nerves associated with tumors, cancer-related pain, organ function and…
2 months ago globenewswire.com
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
Patent expands protection for technology designed to sense, map and selectively target nerves associated with tumors and cancer-related pain
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million. Supernus…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC)…
3 months ago benzinga.com
Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results
US stocks mostly lower, Dow Jones falls 400+ pts. Energy shares up 3%. Procter & Gamble shares down 4% after worse-than-expected sales & EPS. Asian markets mixed.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares…
3 months ago benzinga.com
Why Bloom Energy Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket
Bloom Energy Corp (BE) shares surge in pre-market trading after beating Q2 estimates and raising FY26 guidance. Other gainers include AMIX, STFS, LGHL, GMM, TURB, ONMD, VRRM, BRAI, and LVWR. Losers…
3 months ago benzinga.com
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why
Autonomix Medical shares surged 54.36% after hours, reversing an intraday decline after the company disclosed warrant registration details.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million. CalciMedica (NASDAQ:CALC)…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)…
-
3 months ago benzinga.com
Autonomix Medical Announces Results From Preclinical Study Demonstrating Ability Of Its Neural Sensing Platform To Detect, Localize And Confirm Changes In Renal Neural Activity
The study successfully demonstrated Autonomix's ability to identify neural signals associated with nerve activity along the renal artery and surrounding tissue, providing direct physiological…
3 months ago globenewswire.com
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…
-
3 months ago benzinga.com
Autonomix Medical Awarded U.S. Patent For Autonomic Nervous System Assessment Systems, Kits, And Methods
U.S. Patent No. 12,471,776, titled "ANS Assessment Systems, Kits, and Methods," broadly covers systems, devices and methods for monitoring physiologic signals to assess autonomic nervous system (ANS)…
3 months ago globenewswire.com
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.0 million. Catheter Precision…
3 months ago globenewswire.com
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --…